Bradley Foster & Sargent Inc Regeneron Pharmaceuticals, Inc. Transaction History

Bradley Foster & Sargent Inc

$5.82 Billion
Q3 2024

A detailed history of Bradley Foster & Sargent Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Bradley Foster & Sargent Inc holds 1,908 shares of REGN stock, worth $1.34 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,908

Previous 1,863 2.42%

Holding current value

$1.34 Million

Previous $1.96 Million 2.4%

% of portfolio

0.03%

Previous 0.04%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$1024.09 - $1201.76 $46,084 - $54,079	45 Added 2.42%	1,908 $2.01 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $66,799 - $73,507	-74 Reduced 3.82%	1,863 $1.79 Million
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $18,604 - $21,160	-24 Reduced 1.22%	1,937 $1.7 Million
Q2 2022 Aug 11, 2022	BUY	$548.35 - $738.84 $427,713 - $576,295	780 Added 66.05%	1,961 $1.16 Million
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $363,023 - $426,042	610 Added 106.83%	1,181 $825,000
Q3 2021 Nov 10, 2021	BUY	$574.03 - $680.96 $35,589 - $42,219	62 Added 12.18%	571 $346,000
Q2 2021 Aug 19, 2021	BUY	$472.8 - $558.54 $2,364 - $2,792	5 Added 0.99%	509 $284,000
Q1 2021 Apr 26, 2021	SELL	$446.73 - $548.2 $117,936 - $144,724	-264 Reduced 34.38%	504 $238,000
Q4 2020 Feb 11, 2021	BUY	$478.3 - $607.98 $23,915 - $30,399	50 Added 6.96%	768 $371,000
Q3 2020 Oct 26, 2020	BUY	$544.75 - $658.21 $7,626 - $9,214	14 Added 1.99%	718 $402,000
Q1 2020 May 07, 2020	SELL	$336.18 - $494.43 $16,809 - $24,721	-50 Reduced 6.63%	704 $344,000
Q2 2019 Aug 08, 2019	SELL	$299.6 - $414.82 $44,940 - $62,223	-150 Reduced 16.59%	754 $236,000
Q3 2018 Oct 31, 2018	BUY	$351.14 - $408.51 $1,404 - $1,634	4 Added 0.44%	904 $365,000
Q2 2018 Jul 31, 2018	SELL	$284.6 - $344.99 $8,253 - $10,004	-29 Reduced 3.12%	900 $310,000
Q4 2017 Feb 06, 2018	SELL	$358.63 - $469.95 $13,269 - $17,388	-37 Reduced 3.83%	929 $349,000
Q3 2017 Nov 03, 2017	BUY	$431.38 - $504.0 $416,713 - $486,864	966	966 $432,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bradley Foster & Sargent Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bradley Foster & Sargent Inc with notifications on news.

Account

Bradley Foster & Sargent Inc Regeneron Pharmaceuticals, Inc. Transaction History